Gel, plasma locking gel and application
The gel with interwoven pore structures is prepared by using components such as 1,2-hexanediol, para-hydroxyacetophenone and octanyl hydroxamic acid, and locking active particles in the plasma generator, which solves the inability to long-term effect of the copolymer. The problem of locking active particles achieves long-term locking and sustained release of active particles, avoids skin hazards, and provides a safe and effective skin treatment plan.
Patent Information
- Application Number
- CN202411505519.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-28
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-10-28
AI Technical Summary
Existing copolymers cannot hold active particles in the plasma for a long time, and the sustained release effect is poor when applied to the skin surface, which can cause damage to the skin by the electrodes and high-voltage electric shock.
The gel with interwoven pore structure is prepared by 1,2-hexanediol, para-hydroxyacetophenone and octanyl hydroxamic acid, and locks the active particles in the plasma generator to form the locking of the interwoven pore structure. Plasma gel to avoid direct contact with the skin.
It realizes long-term locking and sustained release of active particles, avoids skin burns and electric shock hazards, has good temperature sensitivity and safety, is suitable for large areas and irregular curved surfaces, and the ingredients are non-toxic and non-irritating.
Smart Images

Figure CN119015218A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of plasma biomedical applications, and in particular to a gel, a plasma-locking gel and applications thereof. Background Art
[0002] At room temperature and pressure, voltage is used to break down the gas and discharge, generating atmospheric pressure cold plasma. Atmospheric pressure cold plasma contains NO 3- , O 2- 、NO 2- , H2O2, O3, free electrons and other active particles, these active particles have a good promoting effect in bacterial inactivation, blood coagulation and hemostasis, stimulating cell regeneration, and play a leading role in a variety of biochemical effects. Especially in the fields of medical treatment and beauty, when plasma acts on the skin surface, it can effectively relieve the symptoms of skin diseases such as psoriasis and vitiligo. In addition, plasma can also have a certain effect on relieving skin acne, pimples, inflammation and redness.
[0003] However, if plasma is directly applied to the skin surface, there will be hazards such as skin surface being heated and burned by the electrode, high voltage electric shock to the human body, or inhalation of high concentration ozone. In order to reduce the hazards caused by plasma directly acting on the skin surface, the prior art uses plasma to treat copolymers and then applies them to the skin surface to reduce the hazards caused by plasma directly acting on the skin surface. Existing copolymers are usually prepared using polyethylene glycol, polyacrylic acid, and polyacrylate, but the above copolymers cannot lock the active particles in the plasma for a long time, and the sustained release effect is poor when applied to the skin surface.
[0004] Therefore, it is necessary to provide a gel that can effectively lock active particles in plasma. Summary of the invention
[0005] In order to solve the problem that the existing copolymers cannot lock active particles for a long time and have poor sustained-release effect when applied to the skin surface, the present invention provides a gel, a plasma-locking gel and applications.
[0006] To achieve the above objectives, the specific technical solutions of the present invention are as follows.
[0007] The first aspect of the present invention provides a gel, which is prepared by the following method: At room temperature, 1,2-hexanediol and p-hydroxyacetophenone are added to water, reacted for 10 to 15 minutes, caprylhydroxamic acid is added, reacted for 10 to 15 minutes, a thickener is added, and the mixture is allowed to stand until it becomes a gel, wherein the standing time is 60 to 65 minutes, to obtain the gel.
[0008] The mass percentage of the 1,2-hexanediol in the gel is 0.25% to 0.35%; the mass percentage of the p-hydroxyacetophenone in the gel is 0.15% to 0.25%; the mass percentage of the octanoyl hydroxamic acid in the gel is 0.05% to 0.15%; the mass percentage of the thickener in the gel is 0.5% to 1.5%; the rest is water, which is 100%. The gel prepared by the present invention has an interwoven pore structure and is sensitive to temperature changes.
[0009] In another preferred implementation, the thickener is ammonium acryloyldimethyltaurate / VP copolymer.
[0010] The second aspect of the present invention provides a plasma-locking gel, wherein the plasma-locking gel is prepared by the following method: The gel provided by the first aspect of the present invention is placed in a plasma generator. In a closed environment, the air is ionized by the plasma generator to generate active particles, and the active particles are locked by the gel to obtain a gel that locks plasma.
[0011] In another preferred embodiment, the active particles include NO 3- , O 2- 、NO 2- , H2O2, O3 and free electrons.
[0012] In another preferred embodiment, the plasma generator includes a sheet metal electrode, a mesh metal electrode, and a composite blocking medium.
[0013] The sheet metal electrode and the mesh metal electrode are respectively arranged on both sides of the composite blocking medium; when voltage is applied, plasma will be generated on one side of the mesh metal electrode.
[0014] In another preferred embodiment, the composite barrier medium is obtained by spraying molten polytetrafluoroethylene on both sides of the boron nitride ceramic at 342° C. The composite barrier medium has both the electrical properties of polytetrafluoroethylene and the mechanical properties of ceramics, which can ensure that during use, while discharging stably, the electrode heats up slowly and will not be electrically broken down.
[0015] In another preferred embodiment, the thickness of the polytetrafluoroethylene spray coating is 20 μm to 40 μm.
[0016] In another preferred embodiment, the sheet-shaped metal electrode and the mesh-shaped metal electrode correspond one-to-one to the two side surfaces of the composite barrier medium sprayed with polytetrafluoroethylene.
[0017] The third aspect of the present invention provides an application of a plasma-locked gel in the preparation of an anti-acne product, wherein the plasma-locked gel is provided by the second aspect of the present invention.
[0018] A fourth aspect of the present invention provides a use of a plasma-locked gel in the preparation of a hemostatic product, wherein the plasma-locked gel is provided by the second aspect of the present invention.
[0019] Compared with the prior art, the present invention has the following beneficial effects: 1. The 1,2-hexanediol and p-hydroxyacetophenone in the gel of the present invention can make the obtained gel have good temperature sensitivity, and by adding octanoyl hydroxamic acid and a thickener, the obtained gel has an interlaced pore structure for long-term locking of active particles.
[0020] 2. The plasma-locking gel of the present invention locks the active particles for a long time through interlaced pores, and has good temperature sensitivity, and can release the active particles in the pores when the external temperature rises, thereby having a good sustained-release effect.
[0021] 3. The plasma-locking gel of the present invention can effectively lock active particles generated under atmospheric pressure. The active particles can maintain their activity in the gel for a long time, and can be applied to large areas of the body and irregular surfaces. In addition, the gel component of the present invention is non-toxic and non-irritating. When applied to the skin, it can effectively improve skin quality, alleviate skin diseases, and avoid the side effects of oral or topical antibiotics and hormone drugs. It can also be used for a long time or repeatedly, and the human body will not develop dependence and drug resistance.
[0022] 4. The plasma-locking gel of the present invention is processed by a plasma generator so that the active particles are locked in the gel and then applied to the skin surface. This can prevent the plasma generator from directly contacting the body surface or from close contact through the air, thereby preventing skin burns and electric shocks, and is extremely safe. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 Schematic diagram of the structure of the composite barrier medium in Example 4 of the present invention.
[0024] Figure 2 This is a schematic diagram of the structure of the plasma generator in Example 4 of the present invention.
[0025] Figure 3 Schematic diagram of the preparation process of the plasma-locking gel in Example 4 of the present invention.
[0026] Figure 4 This is a schematic diagram of the sustained-release process of applying the plasma-locked gel to the skin surface in Example 4 of the present invention.
[0027] Figure 5 These are infrared spectrum structure diagrams of the gel in Example 1 of the present invention and the gel that locks plasma in Example 4; wherein A is an infrared spectrum structure diagram of the gel in Example 1 of the present invention, and B is an infrared spectrum structure diagram of the gel that locks plasma in Example 4.
[0028] Figure 6 These are oxygen content graphs taken by scanning electron microscope of the gel in Example 1 of the present invention and the gel with locked plasma in Example 4; wherein, A is the oxygen content graph taken by scanning electron microscope of the gel in Example 1 of the present invention, and B is the oxygen content graph taken by scanning electron microscope of the gel with locked plasma in Example 4.
[0029] Figure 7 These are nitrogen content graphs of the gel in Example 1 of the present invention and the plasma-locked gel in Example 4, taken by a scanning electron microscope; wherein A is a nitrogen content graph of the gel in Example 1 of the present invention, taken by a scanning electron microscope, and B is a nitrogen content graph of the gel with plasma locked in Example 4, taken by a scanning electron microscope.
[0030] Figure 8 These are the pictures showing the effects of acne on day 0, day 7 and day 14 for a pimple that has not been coated with the plasma-locking gel; wherein, A is the picture showing the effects on day 0, B is the picture showing the effects on day 7, and C is the picture showing the effects on day 14.
[0031] Fig. 9 These are the pictures showing the effects of applying the plasma-locking gel acne in Example 4 of the present invention on day 0, day 7 and day 14; wherein A is the picture showing the effects on day 0, B is the picture showing the effects on day 7, and C is the picture showing the effects on day 14.
[0032] Fig.10 The figures are diagrams showing the effect of the plasma-locked gel in Example 4 of the present invention on hemostasis of the femoral artery of mice; wherein, A is a diagram showing the effect of the plasma-locked gel in Example 4 of the present invention not being used; and B is a diagram showing the effect of the plasma-locked gel in Example 4 of the present invention being used.
[0033] Among them: 1. Polytetrafluoroethylene layer; 2. Boron nitride ceramic layer; 3. Sheet metal electrode; 4. Mesh metal electrode; 5. Plasma generator; 6. Open container; 7. Gel; 8. Skin section. DETAILED DESCRIPTION
[0034] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0035] Unless otherwise specified, the experimental methods described in the following examples are all conventional methods; the reagents and materials described are all commercially available unless otherwise specified.
[0036] In the following examples, Escherichia coli and Staphylococcus aureus were purchased from the Xi'an Jiaotong University Chemical Reagent Information Management System Mall. Mice were purchased from the Experimental Animal Center of Xi'an Jiaotong University, and were 7 weeks old and weighed 17 g ± 0.2 g.
[0037] Example 1 A method for preparing a gel comprises the following steps: S1. Heat ultrapure water to 85°C, keep warm for 10 minutes and then cool to room temperature to obtain cooled ultrapure water.
[0038] S2. Add 1,2-hexanediol and p-hydroxyacetophenone into cooled ultrapure water, stir and react for 10 minutes, add octanoyl hydroxamic acid, stir and react for 10 minutes, add ammonium acryloyldimethyltaurate / VP copolymer, stir and react for 10 minutes, and finally stand for 60 minutes to obtain a gel.
[0039] Among them, 1,2-hexanediol accounts for 0.3% of the mass percentage of the gel, p-hydroxyacetophenone accounts for 0.2% of the mass percentage of the gel, octanoylhydroxamic acid accounts for 0.1% of the mass percentage of the gel, ammonium acryloyldimethyltaurate / VP copolymer accounts for 1% of the mass percentage of the gel, and the rest is water, totaling 100%.
[0040] Example 2 A method for preparing a gel comprises the following steps: S1. Ultrapure water is heated to 85°C, kept warm for 10 minutes and then cooled to room temperature to obtain cooled ultrapure water.
[0041] S2. Add 1,2-hexanediol and p-hydroxyacetophenone into cooled ultrapure water, stir and react for 15 minutes, add octanoyl hydroxamic acid, stir and react for 15 minutes, add ammonium acryloyldimethyltaurate / VP copolymer, stir and react for 15 minutes, and finally stand for 65 minutes to obtain a gel.
[0042] Among them, 1,2-hexanediol accounts for 0.25% by mass of the gel, p-hydroxyacetophenone accounts for 0.15% by mass of the gel, octanoylhydroxamic acid accounts for 0.05% by mass of the gel, ammonium acryloyldimethyltaurate / VP copolymer accounts for 0.5% by mass of the gel, and the rest is water, totaling 100%.
[0043] Example 3 A method for preparing a gel comprises the following steps: S1. Ultrapure water is heated to 85°C, kept warm for 10 minutes and then cooled to room temperature to obtain cooled ultrapure water.
[0044] S2. Add 1,2-hexanediol and p-hydroxyacetophenone into cooled ultrapure water, stir and react for 10 minutes, add octanoyl hydroxamic acid, stir and react for 10 minutes, add ammonium acryloyldimethyltaurate / VP copolymer, stir and react for 10 minutes, and finally stand for 60 minutes to obtain a gel.
[0045] Among them, 1,2-hexanediol accounts for 0.35% by mass of the gel, p-hydroxyacetophenone accounts for 0.25% by mass of the gel, octanoylhydroxamic acid accounts for 0.15% by mass of the gel, ammonium acryloyldimethyltaurate / VP copolymer accounts for 1.5% by mass of the gel, and the rest is water, totaling 100%.
[0046] The above-mentioned Examples 1 to 3 all prepared a gel with comparable effects. The gel prepared in Example 1 is used as an example for description below.
[0047] Example 4 A plasma-locking gel, wherein the plasma-locking gel is prepared by placing the gel obtained by implementing step 1 in a plasma generator. The specific structure of the plasma generator is as follows: like Figure 1 and Figure 2 As shown, the plasma generator 5 includes a sheet metal electrode 3, a mesh metal electrode 4 and a composite blocking medium.
[0048] The sheet metal electrode 3 and the mesh metal electrode 4 are respectively arranged on both sides of the composite barrier medium. In this embodiment, the thickness of the sheet metal electrode 3 is 2 mm, the thickness of the mesh metal electrode 4 is 0.5 mm, the mesh of the mesh metal electrode 4 is a regular hexagon, the side width of each regular hexagonal mesh is 0.75 mm, and the distance between two opposite sides is 4 mm. The embodiment of the present invention does not set specific restrictions on the size of the sheet metal electrode 3 and the mesh metal electrode 4, and can be set according to actual needs. The sheet metal electrode 3 and the mesh metal electrode 4 are respectively connected to a pair of opposite sinusoidal high voltages. When the voltage is loaded, plasma will be generated on one side of the mesh metal electrode.
[0049] The composite barrier medium includes a boron nitride ceramic layer 2 and a polytetrafluoroethylene layer 1, wherein the polytetrafluoroethylene layer 1 is located on both sides of the boron nitride ceramic layer 2. A sheet metal electrode 3 is disposed on one polytetrafluoroethylene layer 1, and a mesh metal electrode 4 is disposed on another polytetrafluoroethylene layer 1. In this embodiment, the working area of the plasma generator 5 is 12.56 cm 2 The embodiment of the present invention does not set any specific limitation on the working area of the plasma generator 5, and it can be set according to actual needs.
[0050] The specific preparation process of the composite barrier medium is as follows: The boron nitride flake ceramic is used as the substrate, with a thickness of 1 mm, and is made into a designed shape according to the design requirements. The shape of the boron nitride flake ceramic in this embodiment matches the shape of the flake metal electrode 3 and the mesh metal electrode 4. The flake boron nitride ceramic is treated with a high-speed sandblasting process on both sides to make its roughness reach Ra150~200. At 342°C, molten polytetrafluoroethylene is evenly sprayed on the surfaces of both sides of the substrate in micron-level droplets with a spray thickness of 20 microns. After drying and condensation, a composite barrier medium is obtained.
[0051] The method for preparing the plasma-locking gel comprises the following steps: S1. In a closed environment, the gel in Example 1 is placed in an open container 6 so that the distance between the liquid surface of the gel and the mesh metal electrode 4 is 5 mm.
[0052] S2, such as Figure 3 As shown, the plasma generator 5 is started. At 6.5 kV, the plasma generator 5 generates plasma when working in the ambient air. At the same time, the mesh metal electrode 4 gradually heats up to 42±5°C. When the temperature is transmitted to the liquid surface of the gel 7, the gel 7 on the surface of the liquid surface changes from viscous to thin, and the water evaporates and rises to the vicinity of the mesh metal electrode 4 in the form of gas. At this time, the water molecules are fully mixed with the plasma and aggregated into extremely small liquid droplets, and then fall back to the surface of the gel 7, so that a very small concentration difference is formed between the liquid surface and the interior of the gel 7, and then the liquid droplets are quickly adsorbed, so that the liquid droplets mixed with active particles enter the interior of the gel 7 and are locked in the gaps of the microporous interwoven structure; after 5 minutes, a large number of active particles in the plasma will be locked in the gel, and a gel that locks the plasma will be obtained.
[0053] Figure 4The schematic diagram is a schematic diagram of the sustained-release application process of the gel that locks active particles on the skin surface. It can be seen from the skin section 8 that after the plasma-locking gel is evenly applied, a thin film is formed on the skin surface. When the body temperature is transmitted to the plasma-locking gel, the plasma-locking gel gradually changes from viscous to thin, and water molecules mixed with active particles gradually precipitate from the plasma-locking gel. At this time, due to the difference in cell fluid concentration between the inside and outside of the epidermal cells, the water molecules bound to the active particles can enter the cells, and the active nitrogen particles in the active particles will enhance cell metabolism and stimulate cell proliferation, which plays a positive role in maintaining skin health. At the same time, a part of the water molecules bound to the active particles are attached to the skin surface, and the active oxygen particles and nitrogen oxide particles in the active particles inactivate the bacteria on the skin surface and in the wrinkles, which can disinfect the skin. Another part of the water molecules bound to the active particles can pass through the pores to the subcutaneous tissue, and have an anti-inflammatory and anti-inflammatory effect on the subcutaneous cell tissue.
[0054] Figure 5 A in the figure is the gel in Example 1 of the present invention, i.e., the gel that has not been subjected to plasma treatment. Figure 5 B in the figure is the plasma-locked gel in Example 4, i.e., the plasma-locked gel obtained after plasma treatment. Figure 5 It can be seen that after the plasma treatment, the structure of the plasma-locked gel in Example 4 becomes more cross-linked and dense compared to the structure of the gel in Example 1.
[0055] Figure 6 A in FIG. 1 is a graph showing the oxygen content of the gel in Example 1 of the present invention taken by a scanning electron microscope. Figure 6 B is a graph of oxygen content of the plasma-locking gel in Example 4 taken by a scanning electron microscope. Figure 6 It can be seen that after plasma treatment, the oxygen content in the plasma-locked gel in Example 4 is significantly higher than that in the gel in Example 1 of the present invention, indicating that the oxygen element is effectively locked in the gel through plasma treatment.
[0056] Figure 7 A in FIG. 1 is a nitrogen content diagram of the gel in Example 1 of the present invention taken by scanning electron microscope. Figure 7 B is a nitrogen content image of the plasma-locking gel in Example 4 taken by scanning electron microscope. Figure 7 It can be seen that after plasma treatment, the nitrogen content in the plasma-locked gel in Example 4 is significantly higher than that in the gel in Example 1 of the present invention, indicating that the nitrogen is effectively locked in the gel through plasma treatment.
[0057] In order to further prove the effect, the following comparative test was conducted.
[0058] 1. Comparative test of acne removal effect.
[0059] The plasma-locking gel prepared in Example 4 was applied to the surface of the acne on the skin. After 30 to 60 minutes, the applied plasma-locking gel was dried and then washed with clean water. This was used as the experimental group. According to the above operation, the gel was applied every day, and photos were taken on the 0th day, 7th day, and 14th day. The results are as follows: Fig. 9 shown.
[0060] The uncoated group was used as the control group, and photographs were taken on days 0, 7, and 14. The results are as follows: Figure 8 shown.
[0061] from Figure 8 and Fig. 9 It can be seen from the results that the gel with locked plasma in Example 4 of the present invention can effectively reduce the area of acne and has a certain acne removal effect. This is mainly because during the plasma treatment process, the gel will effectively lock the active particles in the plasma in the microporous interwoven structure inside it during the physical form transformation process. The gel with locked active particles is taken out and applied to the skin surface, and the active particles inside can adhere to the epidermis to maintain the skin.
[0062] 2. Comparative test of hemostatic effect.
[0063] The plasma-locking gel prepared by the method in Example 4 was applied to the bleeding wound of the femoral artery of mice for 30 to 60 minutes. After the applied plasma-locking gel was dried, it was washed with clean water and used as the experimental group; the uncoated group was used as the control group for photographing and recording. The results are shown as follows: Fig.10 shown.
[0064] from Fig.10 It can be seen that the amount of bleeding from the femoral artery bleeding wound of the mouse coated with the plasma-locked gel in Example 4 was significantly reduced, indicating that the plasma-locked gel in Example 4 of the present invention has a certain coagulation effect.
[0065] 3. Sterilization performance test.
[0066] The plasma-locked gel in Example 4 was used to measure the sterilization effect on Escherichia coli and Staphylococcus aureus as experimental groups, and three parallel experiments were performed in each group; the plasma-locked gel not using Example 4 was used as a positive control group, and the results are shown in Table 1.
[0067] Table 1 Sterilization test results
[0068] It can be seen from the results in Table 1 that the plasma-locked gel in Example 4 of the present invention has a good sterilization effect on Escherichia coli and Staphylococcus aureus.
[0069] 4. Toxicity testing.
[0070] The plasma-locking gel in Example 4 of the present invention was subjected to an acute oral test, a skin irritation test and a mouse bone marrow polychromatic erythrocyte micronucleus test in accordance with Technical Specifications for Disinfection, 2002 Edition, Part 2, 2.3.1, 2.3.3, and 2.3.8.4.
[0071] The results of acute oral toxicity test showed that the acute oral toxicity LD 50 >5000mg / kg.BW, which is practically non-toxic and meets the requirements of 2.3.13.1 of the Disinfection Technical Specifications 2002 Edition.
[0072] The results of multiple completed skin irritation tests showed that the test substance was non-irritating to New Zealand rabbits, which met the requirements of 2.3.13.1 of the Disinfection Technical Specifications 2002 Edition.
[0073] The results of the mouse bone marrow polychromatic erythrocyte micronucleus test showed that the test substance was negative in the mouse bone marrow polychromatic erythrocyte micronucleus test, which met the requirements of 2.3.13.2 of the Disinfection Technical Specifications 2002 Edition.
[0074] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A gel, It is characterized in that The gel is prepared by the following method: At room temperature, 1,2-hexanediol and p-hydroxyacetophenone are added to water, reacted for 10 to 15 minutes, caprylhydroxamic acid is added, reacted for 10 to 15 minutes, a thickener is added, and allowed to stand until it becomes a gel, wherein the standing time is 60 to 65 minutes, to obtain the gel; The mass percentage of 1,2-hexanediol in the gel is 0.25% to 0.35%; The mass percentage of the p-hydroxyacetophenone in the gel is 0.15% to 0.25%; The mass percentage of the caprylhydroxamic acid in the gel is 0.05% to 0.15%; The mass percentage of the thickener in the gel is 0.5% to 1.5%; the rest is water, which is 100% in total.
2. The gel according to claim 1, It is characterized in that The thickener is ammonium acryloyldimethyltaurate or VP copolymer.
3. A gel that locks in plasma, It is characterized in that The plasma-locking gel is prepared by the following method: The gel described in claim 2 is placed in a plasma generator, the air is ionized by the plasma generator to generate active particles, and the active particles are locked by the gel to obtain a gel that locks plasma.
4. The plasma-locking gel according to claim 3, It is characterized in that The active particles include NO 3- , O 2- 、NO 2- , H 2 O 2 , O 3 and free electrons.
5. The plasma-locking gel according to claim 3, It is characterized in that The plasma generator comprises a sheet metal electrode, a mesh metal electrode and a composite blocking medium; The sheet metal electrode is arranged on one side of the composite barrier medium; The mesh metal electrode is disposed on the other side of the composite blocking medium.
6. The plasma-locking gel according to claim 5, It is characterized in that The composite barrier medium is obtained by using boron nitride ceramic as a substrate and spraying molten polytetrafluoroethylene onto both sides of the boron nitride ceramic at 342°C.
7. The plasma-locking gel according to claim 6, It is characterized in that The thickness of the polytetrafluoroethylene spray coating is 20 μm.
8. The plasma-trapping gel according to claim 7, It is characterized in that The sheet metal electrode and the mesh metal electrode correspond to the two side surfaces of the composite blocking medium sprayed with polytetrafluoroethylene respectively.
9. Use of the plasma-locking gel according to claim 3 in the preparation of acne-removing products.
10. Use of the plasma-locking gel according to claim 3 in the preparation of hemostatic products.
Citation Information
Patent Citations
Plasma generating device and plasma gel preparation method
CN109890121A
Mist spray mask capable of coagulating after skin temperature sensing, and preparation method
CN111297703A
Skin surface treatment device and method based on low-temperature plasma
CN114392486A
Slow-release composition with anti-irritation effect as well as preparation method and application of slow-release composition
CN115252463A
Bletilla striata acne-removing repair gel and preparation method thereof
CN115517982A
Cited By
Plasma skin care instrument and use method thereof
CN120346451A
Plasma activated nano-silver gel as well as preparation method and application thereof
CN122124097A
